InvestorsHub Logo
Followers 57
Posts 5700
Boards Moderated 0
Alias Born 12/13/2004

Re: biopharm post# 149965

Saturday, 11/23/2013 2:30:36 PM

Saturday, November 23, 2013 2:30:36 PM

Post# of 346123
Yes Bio...this is very big. Dr.Garnicks attitude can be explained that with a look-in that can be determined by the information gathered by markers in the blood...that will mean that the Phase III approval can happen a lot earlier than some think. The Phase II trial had only 40 patients in each arm and if memory serves me there was a statistically significant difference between the high dose arm and the placebo arm(even if some in the placebo received a small dose!). They may only need 80-100 in each arm of the Phase III trial...and the blood markers should tell them all they need to know!

"The refusal of the real is the number one dogma of our time" Rene Girard

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News